Back to results
US 2003/0149009 A1Published application
Corticosteroid formulation comprising less than 2.5 mg prednisolone for once daily administration
AssigneeArakis Ltd.
InventorsHazel Judith Bardsley, Robin Mark Bannister, Julian Clive Gilbert
Life of this patent
Estimating the term…
Abstract
The subject invention concerns a unit dose formulation comprising less than 2.5 mg of prednisolone or an equivalent, equipotent amount of another corticosteroid. One embodiment of a method of the invention concerns once daily administration of the unit dose formulation between midnight and 6 a.m. for the treatment of rheumatoid arthritis.
Claims17
A unit dose formulation comprising less than 2.5 mg of prednisolone or an equivalent, equipotent amount of another corticosteroid.
Dependencies are inferred from the claim text.